August 18, 2017 2:58 AM ET

Biotechnology

Company Overview of AmpliPhi Biosciences Corporation

Executive Profile

Paul C. Grint M.D.

AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 12 different industries.

See Board Relationships
59$45,000

Background

Dr. Paul C. Grint, M.D., has been the Chief Executive Officer of AmpliPhi Biosciences Corporation since May 31, 2017. Dr. Grint served as the Chief Executive Officer and President of Regulus Therapeutics Inc. since June 1, 2015 until May 4, 2017 and served as its Chief Medical Officer from June 16, 2014 to June 1, 2015. Dr. Grint has over two decades of experience in biologics and small molecule development, including the successful commercialization of products in oncology, ...

Corporate Headquarters

3579 Valley Centre Drive
San Diego, California 92130

United States

Phone: 858-829-0829
Fax: --

Board Members Memberships

Director
2008-Present
Director
2015-Present
CEO & Director
2016-Present
Director

Education

BS
Barts & The London School of Medicine & Dentistry, Queen Mary University of London
MD
Saint Bartholomew Medical School, London University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$440
Unexercisable Options$1,180
Total Number of Options$1,620

Total Compensation

Total Annual Cash Compensation$45,000
Total Calculated Compensation$45,000
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AmpliPhi Biosciences Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.